AXIN1 and hepatocellular carcinoma: For HCC, the most frequent alterations in Wnt pathway components comprise activating mutations in β-catenin (gene name: CTNNB1, mutated in 28%–40% of cases) and inactivating mutations in AXIN1 (mutated in 11% of cases).7